Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review

The new drugs delamanid and bedaquiline are increasingly used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB). As evidence is lacking, the World Health Organization recommends their use under specific conditions in adults, delamanid only being recommended in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Thorac Dis
Glavni autori: D’Ambrosio, Lia, Centis, Rosella, Tiberi, Simon, Tadolini, Marina, Dalcolmo, Margareth, Rendon, Adrian, Esposito, Susanna, Migliori, Giovanni Battista
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2017
Teme:
Review Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542985/
https://ncbi.nlm.nih.gov/pubmed/28840010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.06.16
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items